Host Nate Kaufman brings Rich Helppie back for a discussion about healthcare access. A 30-day wait for a first oncology visit after hearing the word leukemia is not an edge case—it’s the new normal in a system where demand outpaces supply and incentives reward the wrong behaviors. Nate opens with a personal story that reveals how access feels when the stakes are life and death, then pulls back the lens to explain why it happens: a 12-year training pipeline for specialists, uneven reimbu...
All content for Richard Helppie's Common Bridge is the property of Richard Helppie and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Host Nate Kaufman brings Rich Helppie back for a discussion about healthcare access. A 30-day wait for a first oncology visit after hearing the word leukemia is not an edge case—it’s the new normal in a system where demand outpaces supply and incentives reward the wrong behaviors. Nate opens with a personal story that reveals how access feels when the stakes are life and death, then pulls back the lens to explain why it happens: a 12-year training pipeline for specialists, uneven reimbu...
Episode 289- College Sports' Money Game. With Dr. Thomas Dieters
Richard Helppie's Common Bridge
28 minutes
1 month ago
Episode 289- College Sports' Money Game. With Dr. Thomas Dieters
The money is already here—so why are the rules still stuck in limbo? We sit down with Tom Dieters to map how NIL evolved from booster-led collectives into university-controlled revenue sharing after House v. NCAA, and what that shift means for athletes across every sport. From donor intent getting sidelined by caps to student fees propping up compensation, we confront the uncomfortable question: if this is now a professional marketplace, who should set the rules and who should be accountable?...
Richard Helppie's Common Bridge
Host Nate Kaufman brings Rich Helppie back for a discussion about healthcare access. A 30-day wait for a first oncology visit after hearing the word leukemia is not an edge case—it’s the new normal in a system where demand outpaces supply and incentives reward the wrong behaviors. Nate opens with a personal story that reveals how access feels when the stakes are life and death, then pulls back the lens to explain why it happens: a 12-year training pipeline for specialists, uneven reimbu...